Nel ASA's $20 Million Submarine Order Book Won't Reach the P&L Until 2027
Published on 10/01/2026 at 18:41 | Editorial boerse-global.de
Nel ASA has locked in roughly USD 20 million of submarine-related business through its US subsidiary, but the Norwegian hydrogen group has also confirmed that the hardware behind those contracts won't ship until 2027 and 2028 — a gap that leaves investors staring at several lean quarters before any of it shows up as revenue.
The orders, placed by Collins Aerospace, cover PEM electrolyser stacks used to generate oxygen for life-support systems aboard submarines. They serve naval programmes belonging to the United States, the United Kingdom and France, and they carry the kind of exacting military specifications that few suppliers are qualified to meet. Nel Hydrogen US will handle execution.
How the order book was assembled
The tally built up in stages. Nel disclosed a Collins Aerospace booking of about USD 12 million on a Tuesday, then followed with further call-offs worth roughly USD 7 million the next day. Added to smaller awards booked in September, the total for the submarine segment lands at approximately USD 20 million.
All of it will be recognised in the third quarter of 2026, giving the company's backlog a visible lift. Management gets something else out of the arrangement: a measure of breathing room to rebuild capital-market confidence after months of scepticism. The deal also demonstrates that Nel's technology retains its foothold in a demanding naval niche.
Military procurement carries structural advantages that commercial work often lacks. Defence programmes are planned over long horizons and typically come with lower cancellation risk than large-scale civilian projects. Whether specialised contracts of this size can underpin a full re-rating of the business is a separate question — and one the market has so far answered in the negative.
Should investors sell immediately? Or is it worth buying Nel ASA?
A cash-flow gap that has to be bridged
The timing is the crux. A full order book supports sentiment, but it doesn't pay salaries or cover operating costs. Between the moment an order is booked and the moment cash actually arrives, Nel must show that its existing resources can carry the business without resorting to expensive bridge financing.
That challenge sits alongside unresolved questions at the top of the company. More than a month has passed since Nel reported quarterly figures and left the CEO succession open, and roughly three weeks since it announced a cooperation with Hydrasun. The combination of an unfilled leadership post and delivery dates years out captures the dilemma facing shareholders, who must decide how much patience they are willing to extend for operational execution.
What the share price is saying
The equity has offered little encouragement. The stock trades at EUR 0.1906, down 1.7% on the day. Since the quarterly report more than a month ago, it has shed 5.6%. The Q2 numbers, released about three weeks back, were followed by a decline of 2.1%. The Hydrasun tie-up, announced around the same time, has been accompanied by a 3.1% drop.
Market capitalisation stands at EUR 350.90 million, with the shares at EUR 0.1938 in the secondary article's reading — well below the 52-week high of EUR 0.3655. That valuation reflects investor doubt that current order intake alone can deliver a swift recovery. Positive defence news has largely failed to move the needle, and participants say they are missing clear signals of a durable turnaround in the industrial core business. As long as the future leadership remains unclear, caution dominates trading around the name.
The bull case rests on follow-on work
In an optimistic scenario, the Collins Aerospace partnership becomes a dependable growth engine. If Nel Hydrogen US meets the military specifications on schedule, repeat orders for additional submarine units could follow. Sustained demand from the defence and specialty sector would also bring steadier margins. Should allied navies widen their programmes, Nel could cement a permanent place in international procurement chains, spreading fixed production costs more efficiently and lifting profitability in the stack business.
Flawless execution would double as a technological reference. When defence ministries in three countries commit to a system, it signals manufacturing reliability — the kind of endorsement that might persuade civilian customers to place larger, binding orders of their own.
Nel ASA at a turning point? This analysis reveals what investors need to know now.
Risks on the long runway
The downside is equally clear. If unexpected technical adjustments become necessary before deliveries begin, costs will climb. In fixed-price military contracts, rework can eat sharply into projected margins.
The broader market environment continues to demand strict cost discipline. Quarterly results published more than a month ago underscored persistent pressure on operating earnings. Without new, near-term large orders from other industries, the backlog could erode faster than fresh revenue flows in.
What to watch next
As long as the shares hold their recent lows, the recovery scenario stays alive. A decisive break lower would likely intensify selling pressure. For a lasting trend change, market participants need more than isolated defence awards.
The next concrete milestone is the close of the third quarter of 2026, when the Collins Aerospace orders are booked. Attention will also stay fixed on the vacant leadership position. Only when Nel delivers clarity at the top and proves it can execute new business profitably is the stock likely to win back broader confidence. Until the first PEM stacks ship, the shares remain a waiting game for risk-aware investors: a respectable strategic win in the naval segment, with the real test — scaling and protecting margins — still ahead.
Ad
Nel ASA Stock: New Analysis - 1 October
Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
